• Profile
Close

Mortality is greater in septic patients with hyperlactatemia than with refractory hypotension

Shock Aug 24, 2017

Gotmaker R, et al. – This study entailed the comparison of baseline features, treatments, and outcomes of participants enrolled into the Australian Resuscitation in Sepsis Evaluation (ARISE) trial according to the presence of isolated hyperlactatemia or isolated refractory hypotension. Among the participants in the ARISE trial, a worse adjusted 90–day mortality was observed in those who had isolated hyperlactatemia versus those with isolated refractory hypotension. Isolated hyperlactatemia possibly defined greater illness severity and worse outcomes than isolated refractory hypotension in septic patients.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay